TRML - Financial Reports List - Tourmaline Bio, Inc. - IntrinsicAlpha

Tourmaline Bio, Inc. TRML

Healthcare - Biotechnology - NASDAQ - US

$ 16.42

1.42 %

$ 422 M

Market Cap

-5.08

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	-72.56%	-49.75%
Quarterly Report	Q4	8-K	2024-12-31	-98.24%	-1045.86%	-628.95%
Annual Report	FY	10-K	2024-12-31	0.00%	-73.80%	-97.61%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-187.63%	-173.60%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-8.42%	-34.18%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-77.43%	-133.50%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	43311.38%	83494.31%
Annual Report	FY	10-K	2023-12-31	0.00%	-113.82%	-130.49%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-358723.53%	-456779.80%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-128295.16%	-130245.49%

1